Angell, Marcia
September 1995
New Republic;9/11/95, Vol. 213 Issue 11, p17
Asserts that the only way to learn the health effects of breast implants is through careful research and unbiased interpretation of results. Response of women to the decision of U.S. Food and Drug Administration Commissioner David Kessler to ban silicone gel-filled breast implants; Number of lawsuits filed by lawyers on behalf of women with breast implants; Claim that breast implants could cause various disorders; Conclusion of studies on the correlation of breast implants with diseases; Limitation of the use of expert witness in medical malpractice cases; Legality of medical product liability.


Related Articles

  • Health Risk or a Woman's Choice? Querna, Elizabeth // U.S. News & World Report;4/25/2005, Vol. 138 Issue 15, p57 

    Discusses emotionally charged hearings at a Food and Drug Administration advisory panel meeting on whether silicone breast implants should be restricted as a health hazard or offered as a woman's personal choice. FDA panel recommendation to approve Mentor's silicone implant while rejecting...

  • IMPLANTS: MIXED O.K. Bjerklie, David // Time;10/27/2003, Vol. 162 Issue 17, p79 

    Reports that a Food and Drug Administration advisory panel voted 9 to 6 to recommend that silicone breast implants be allowed back on the market. Their sale was halted in 1992 because of concerns that leaking implants could cause serious illness. Later studies found no evidence that implants...

  • Silicone's Second Act. Jerome, Richard; Hannah, John; Podesta, Jane Sims; Sheff-Cahan, Vicki // People;10/20/2003, Vol. 60 Issue 16, p103 

    The FDA may bring back silicone breast implants--but not without a fight from angry women. Diagnosed with advanced breast cancer two decades ago, Sybil Goldrich underwent a double mastectomy at age 44--then promptly consulted plastic surgeons about silicone gel implants, which since the early...

  • Second Thoughts on BREASTS. Shlaes, Amity // American (19328117);Mar/Apr2007, Vol. 1 Issue 3, p53 

    The article focuses on the decision of the U.S. Food and Drug Administration (FDA) to reverse a ban on silicone-filled breast implants in November 2006. It states that Dow Corning started producing the implants, both for cosmetic augmentation and reconstruction after mastectomies. It also notes...

  • Interference of breast implants with echocardiographic image acquisition and interpretation. Movahed, Mohammad-Reza // Cardiovascular Ultrasound;2007, Vol. 5, p9 

    Echocardiography is one of the most important diagnostic testing in cardiology. The presence of a breast implant overlying heart can cause significant impairment of the echocardiographic acoustic window. Breast implants are increasing in popularity in the USA and the Federal Drug and Food...

  • The 5th Generation. Maxwell, G. Patrick // Plastic Surgery Products;Aug2007, p24 

    The article focuses on silicone breast implants. The fourth-generation implants approved by the U.S. Food & Drug Administration are safer, stronger and they have been quickly accepted by women in the country. The cohesive silicone gel in these implants is similar to a thick hair gel. It notes...

  • Making an INFORMED DECISION About Breast Implants. Rados, Carol // FDA Consumer;Sep2004, Vol. 38 Issue 5, p32 

    Provides information on the breast implant process. Types of breast implants; Controversy over the use of silicones in the surgery; Risks associated with the procedure; Meeting held by the U.S. Food and Drug Administration in October 2003 to discuss a manufacturer's premarket approval for a...

  • Return to Silicone City? Landman, Beth // New York;4/25/2005, Vol. 38 Issue 14, p13 

    Reports on the expectation of plastic surgeons for the business to recover if the U.S. Food and Drug Administration heeds its advisory committee's recommendation to lift the ban on silicon breast implants made by Mentor in New York. Statement of Lawrence Reed, a surgeon from Park Avenue who has...

  • Solid Strategies in Revisional Breast Surgery. Oliver Jr., Robert // Plastic Surgery Products;Apr2008, Vol. 18 Issue 5, p28 

    The article presents a discussion about reoperation of women who underwent breast augmentation. According to data collected by Allergan Inc. and Mentor Corp. submitted to the U.S. Food and Drug Administration (FDA), reoperation rates of women within 5 years of surgery are high. One factor that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics